Saturday, March 19, 2022
Bioweapon Agreement between USA DND and Ukraine. 2022-03-09. Jorma Jyrkkanen, BSc, PDP
https://www.state.gov/wp-content/uploads/2019/02/05-829-Ukraine-Weapons.pdf
TREATIES AND OTHER INTERNATIONAL ACTS SERIES 05-829
________________________________________________________________________
WEAPONS
Proliferation
Agreement Between the
UNITED STATES OF AMERICA
and UKRAINE
Signed at Kiev August 29, 2005
NOTE BY THE DEPARTMENT OF STATE
Pursuant to Public Law 89—497, approved July 8, 1966
(80 Stat. 271; 1 U.S.C. 113)—
“. . .the Treaties and Other International Acts Series issued
under the authority of the Secretary of State shall be competent
evidence . . . of the treaties, international agreements other than
treaties, and proclamations by the President of such treaties and
international agreements other than treaties, as the case may be,
therein contained, in all the courts of law and equity and of maritime
jurisdiction, and in all the tribunals and public offices of the
United States, and of the several States, without any further proof
or authentication thereof.”
UKRAINE
Weapons: Proliferation
Agreement signed at Kiev August 29, 2005;
Entered into force August 29, 2005.
NOTE BY THE DEPARTMENT OF STATE
Pursuant to Public Law 89—497, approved July 8, 1966
(80 Stat. 271; 1 U.S.C. 113)—
“. . .the Treaties and Other International Acts Series issued
under the authority of the Secretary of State shall be competent
evidence . . . of the treaties, international agreements other than
treaties, and proclamations by the President of such treaties and
international agreements other than treaties, as the case may be,
therein contained, in all the courts of law and equity and of maritime
jurisdiction, and in all the tribunals and public offices of the
United States, and of the several States, without any further proof
or authentication thereof.”
UKRAINE
Weapons: Proliferation
Agreement signed at Kiev August 29, 2005;
Entered into force August 29, 2005.
AGREEMENT
between the Department of Defense of the United States of America
and the Ministry of Health of Ukraine
Concerning Cooperation in the Area of Prevention of Proliferation of
Technology, Pathogens and Expertise that could be Used in the Development of
· Biological Weapons
The Department of Defense of the United States of America ("U.S.
Depruiment of Defense") and the Ministry of Health of Ukraine, hereinafter referred
to jointly as the Parties,
l desiring to implement the Agreement between the United States of America
j and Ukraine Concerning Assistance to Ukraine in the Elimination of Strategic
:. Nuclear Arms, and the Prevention of Proliferation of Weapons of Mass Destruction,
signed October 25, 1993, as extended and amended (hereinafter the Umbrella
lAgreement), as it pertains to the prevention of proliferation of technology,
and expertise that could be used in the development of biological
recognizing the existing cooperation between the Science and Technology
Center Ulaaine and the Lviv Scientific Research Institute of Epidemiology and
Hygiene, and noting that pursuant to Article II of the Umbrella Agreement, the Ministry of ~
Health of Ukraine has been designated by the Government of Ukraine (Cabinet of ~
Ministers) as the executive agent to implement this Agreement, I
HAVE AGREED AS FOLLOWS:
Article I
J" 1. In order to assist Ulaaine in preventing the proliferation of technology,
i pathogens, and expertise that are located at the Scientific Research Institute of
, Epidemiology and Hygiene (Lviv), the Ulaainian Scientific Research Anti-Plague
) Institute (Odessa), the Central Sanitary Epidemiological Station (Kyiv), and other
1 facilities in Ulaaine identified by the Ministry of Health of Ukraine, and that could
! be used in the development of biological weapons, the U.S. Department of Defense
shall provide assistance to the Ministry of Health of Ulaaine at no cost, subject to
the availability of funds appropriated for this purpose, in accordance with the terms
of this Agreement.
2. The Ministry of Health of Ukraine shall use all material (including '
equipment, instruments, and other supplies), training of personnel and services
provided in accordance with this Agreement exclusively for the purpose of
preventing the proliferation of technology, pathogens and expertise that are located
at facilities in Ukraine and that could be used in the development of biological
weapons.
3. This Agreement and all activities undertaken in accordance with this
Agreement shall be subject to the provisions of the Umbrella Agreement. In the
event of any discrepancies between tllis Agreement and the Umbrella Agreement,
the provisions of the Umbrella Agreement shall prevail.
4. The Ministry of Health of Ukraine shall provide to the U.S. Department of
Defense a list of facilities in Ukraine that may receive assistance under this
Agreement, establishing the Ministry of Health of Ulaaine's order of priority for
such assistance.
Article II
j 1. Each party to this Agreement shall have the right, following written
l notification to the other party, to delegate responsibilities for the implementation of
1 this Agreement to other organizations, departments, agencies, or units of their
J respective governments in accordance with the national laws of that party.
2. To coordinate activities under this Agreement, each party to this.
Agreement shall have the right, following written notification to the other party, to
designate technical representatives for material, training and services provided
pursuant to this Agreement.
Article III
1. The total cost to the U.S. Department of Defense of all material, training
and services provided pursuant to this Agreement and the associated expenses shall
be up to fifteen (15) million U.S. dollars.
2. Assistance provided by the U.S. Department of Defense to the Ministly of
Health of Ulaaine under Article I, Paragraph 1 may include, but is not limited to,
cooperative biological research, biological threat agent detection and response, and
assistance for improving biological material protection, control and accountability
in order to reduce the risk of theft or unauthorized use of dangerous pathogens
located at the facilities in Ukraine referred to in Article I, Paragraph 1.
3. Pursuant to the terms ofthis Agreement, the U.S. Department ofDefense
may, at its discretion, provide the Ministry of Health of Ukraine with other types of
assistance subject to the written agreement of the Parties.
Article IV
1. The Ministry of Health of Ukraine shall assist the U.S. Department of
Defense during the implementation of this Agreement.
2. The Ministry of Health of Ukraine shall coordinate with appropriate
Ukrainian ministries and other government agencies and organizations in order to
ensure that:
(a) material provided under this Agreement is afforded priority processing to
allow prompt delivery to its ultimate destination within Ukraine; and
(b) appropriate security measures are provided for the U.S. Department of
·· Defense representatives, contractors, and equipment at those facilities associated
j with activities under this Agreement.
3. The Ministry of Health of Ukraine shall facilitate the examination by the
appropriate Ukrainian ministries and other government agencies and organizations
of all material received pursuant to this Agreement and provide confirmation of the
acceptability of such material to the U.S. Department of Defense within ten days of
receipt of the results of such examinations. Material failing to conform to agreed
specifications shall be returned, at the expense of the U.S. Department of Defense,
to the U.S. Department ofDefense through the Embassy ofthe United States of
America in Kyiv within thirty days of receipt for replacement.
4. The Ministry of Health of Ukraine or its designated agent shall consolidate
and store all dangerous pathogens at secure centralized laboratories designated in
writing by the Parties that have received or. are receiving the U.S. Department of
Defense assistance under this Agreement (hereinafter centralized laboratories). The
U.S. Department of Defense may provide molecular diagnostics capabilities,
improved electronic communications, and equipment for the safe and timely
transport of field pathogen samples to the centralized laboratories.
5. In order to support the joint efforts of the Parties to prevent the
proliferation of dangerous pathogens and related expertise and to minimize potential biological threats, the Ministry of Health of Ukraine shall transfer to the U.S.
J Department of Defense requested copies of dangerous pathogen strains collected in
j Ulaaine for cooperative biological research in the centralized laboratories in . ;
I Ulaaine and in U.S. Department of Defense-designated laboratories in the United
States for prophylactic, protective or other peaceful purposes. Details of such
cooperation shall be defmed in annual Joint Requirements and Implementation
Plans developed in accordance with paragraph 7 of Article IV of this Agreement or
in an implementing arrangement in accordance with Article VI of this Agreement.
The Ministry of Health ofUlaaine shall share with the U.S. Department of Defense
data generated by the infectious disease surveillance network of the Ministry of
Health of Ukraine or its designated agents in order for the Parties to better detect,
diagnose and monitor disease outbreaks in Ulaaine.
6. Dangerous pathogens placed in centralized laboratories shall remain in
l those laboratories for the duration oft he Umbrella Agreement. T he Ministry of
Health of Ukraine shall immediately notify the U.S. Department of Defense in
writing about the temporary removal of dangerous pathogens from centralized
laboratories due to emergency situations. The Ministry of Health of Ukraine shall
return all pathogens removed from a centralized laboratory to that centralized
laboratory or another centralized laboratory as soon as possible.
7. The Ministry of Health of Ulaaine or its designated agent shall cooperate
with the U.S. Department of Defense to develop annual Joint Requirements and
Implementation Plans describing the underlying assumptions, requirements and
responsibilities for implementation of this Agreement, and the Parties or their
designated implementing agents shall sign these plans.I1l
Article V
1. In accordance with Article X of the Umbrella Agreement, the U.S.
Department of Defense has the right to audit and. examine material, training of
personnel, and services provided in accordance with this Agreement to facilities in
Ukraine for the duration of the Umbrella Agreement. Such audits and examinations
may be conducted consistent with the Implementing Arrangements for the Conduct
of Audits and Examinations of United States Assistance to Ukraine in Connection
with the Agreement between the United States and Ulaaine of October 25, 1993.
2. In addition to the rights provided by Article X of the Umbrella Agreement,
1 the U.S. Department of Defense representatives shall also have the right to
1 ·participate in all aspects of implementation of contracts and related activities at
~ facilities in Ukraine pursuant to the terms of this Agreement.
Article VI ;
As appropriate, the Parties may enter into additional implementing .i
arrangements or agreements to carry out the provisions of this Agreement. In the ]
case of any inconsistency between this Agreement and any such arrangements or i
·1 agreements, the provisions of this Agreement shall prevail. 1
;
Article VII
In order to facilitate the provision of assistance in accordance with the terms ]
of this Agreement, and without prejudice to the U.S. Department of Defense's right ;
to conduct audits and examinations in accordance with Article V ofthis Agreement: ·1
1. The information transmitted under this Agreement or developed as a result of its
implementation and considered by the U.S. Department of Defense as "sensitive" or
by the Ministry of Health of U1craine as "restricted information" (in 1Jkrainian:
"KoHcpi,n;eHu;lliHa iHcpopMau;i5I") must be clearly designated and marked as such.
2. "Sensitive" information or "restricted information" shall be protected m .,
accordance with the laws of the state of the pruty receiving the information.
A) According to the 1aws and regulations o fthe United States of America, such
! information shall be treated as "sensitive information of a foreign government", and
j shall be withheld from public disclosure to the extent permitted by the laws and
· regulations of the United States of America. Any such information transmitted by j
J the Ministry ofHealth of Ulcraine to the U.S. Department of Defense must be j
l accompanied by a written declaration from the Government of Ukra'ine which states
J
j that it is withholding such information from .public disclosure and that the
i information is provided to the Government of the United States of America on the . ·•
; condition that it not be released to the public without the approval of the
Government ofUlaaine. In this written declaration, the Government ofUlaaine
shall specify the date until which the information provided should be withheld from
public disclosure by the Government of the United States of America. That date ~
may be extended by the U.S. Department of Defense, to the extent pennitted by the .:
laws and regulations of the United States of America, in accordance with a request ··•
by the Government of Ukraine. ]
B) Information marked or designated by the U.S. Department of Defense as ·;
"sensitive" should be withheld from public disclosure by the Government of
Ukraine.
3. The Parties shall minimize the number of persons who have access to
information that is designated "sensitive" or "restricted information" in accordance _;
with Paragraph 2 of this article.
4. During implementation of this Agreement, access to certain information
and technology considered "state secret of Ukraine" may be provided to the U.S.
Department of Defense in accordance with the provisions of the "Law of Ukraine
on State Secret."
Article VIII
This Agreement shall enter into force upon signature and shall remain in
force for the duration of the Umbrella Agreement. This Agreement may be
amended by the written agreement of the Parties and may be terminated by either
party upon written notification to the other party ninety days prior to its intention to
do so, provided that the provisions of Article N, Paragraph 6 shall continue in force
for the duration of the Umbrella Agreement.
IN WITNESS WHEREOF, the undersigned, being duly authorized by their
respective governments, have signed this Agreement.
DONE AT Kyiv, this 29 day of August, 2005, in duplicate, each in the
English and Ulaainian languages, both texts being equally authentic.
Subscribe to:
Post Comments (Atom)
DARWINIAN EVOLUTIONS CONCLUSION CREATOR IS QUANTUM FIELD DISTURBANCE DYNAMICS ANOMALIES MODIFIED BY SERENDIPITY, PHYSICAL AND ORGANIC EVOLUTION 2025-04-10
We Are the Universe Become Sentient Pondering Itself Courtesy of Disturbance Dynamics in Quantum Fields. We are the Mind of the Universe i...
-
Environment Gene Interactions Just another WordPress.com weblog « Chimp Origin of AIDS in Koprowski’s Live Polio Vaccinations of Leopoldvil...
-
Biden-US Govt DOD Funded ECOHEALTH In Wuhan and 46 others in Ukraine 2023-01-30 in possible contravention of the UN Convention Prohibiting ...
-
FAUCI AND GATES FUNDED GAIN OF FUNCTION ON H5N1 Technical Report: Highly Pathogenic Avian Influenza A(H5N1) Viruses Español | Other Language...
While I was entering the data I was interfered with digitally so that I could not paste the whole document. This is most definitely Secret service interference. They also blocked me from logging the site out. Not a Democracy.
ReplyDeleteIgnore the latter comment.
ReplyDelete